United Therapeutics (UTHR) EBT Margin (2009 - 2026)
United Therapeutics (UTHR) reported EBT Margin of 40.73% for Q1 2026, down 1258.0% on a YoY basis from 3.52% in Q1 2025, and down 27.51% sequentially from 56.19% in Q4 2025.
United Therapeutics (UTHR) EBT Margin (2009 - 2026) Analysis & Trends
United Therapeutics (UTHR) has 18 years of EBT Margin data on file, last reported at 40.73% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 1258.0% year-over-year to 40.73%; the trailing twelve-month figure through Mar 2026 stood at 50.75% (down 148.0% YoY), and the FY2025 full-year result was 53.85%, up 36.0% from the prior year.
- EBT Margin slipped to 40.73% in Q1 2026, from 56.19% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 66.83% in Q1 2022 to a low of 32.26% in Q2 2022.
- A 5-year average of 52.12% and a median of 53.88% in 2024 frame the typical range for EBT Margin.
- Peak annual rise in EBT Margin reached 5826 bps in 2022, while the deepest fall reached 1623 bps in 2022.
- Tracing UTHR's EBT Margin over 5 years: stood at 36.38% in 2022, then jumped by 32 bps to 48.06% in 2023, then rose by 12 bps to 53.88% in 2024, then grew by 4 bps to 56.19% in 2025, then slipped by 28 bps to 40.73% in 2026.
- Business Quant data shows UTHR's EBT Margin at 40.73% in Q1 2026, 56.19% in Q4 2025, and 54.78% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -3.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.73% |
| Dec 31, 2025 | 56.19% |
| Sep 30, 2025 | 54.78% |
| Jun 30, 2025 | 51.14% |
| Mar 31, 2025 | 53.31% |
| Dec 31, 2024 | 53.88% |
| Sep 30, 2024 | 51.89% |
| Jun 30, 2024 | 49.70% |
| Mar 31, 2024 | 58.82% |
| Dec 31, 2023 | 48.06% |
| Sep 30, 2023 | 57.73% |
| Jun 30, 2023 | 56.19% |
| Mar 31, 2023 | 57.59% |
| Dec 31, 2022 | 36.38% |
| Sep 30, 2022 | 60.56% |
| Jun 30, 2022 | 32.26% |
| Mar 31, 2022 | 66.83% |
| Dec 31, 2021 | 33.84% |
| Sep 30, 2021 | 45.96% |
| Jun 30, 2021 | 48.49% |